CEACAM6 and neoplasm: This is the first study to introduce a novel therapeutic approach utilizing a pHLIP-mediated RNA delivery system to enhance the specificity and efficacy of CEACAM6-targeted therapy within an acidic tumor microenvironment in a PDAC model.